2 Bioanalytical System Analyst Ratings, Earnings, Dividends and Insider Trades | $BASI | NASDAQ:BASI | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Bioanalytical System Company Profile (NASDAQ:BASI) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Bioanalytical System (NASDAQ:BASI) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Sell Rating(s)Consensus Rating:Sell (Score: 1.00)Consensus Price Target: N/A Analysts' Ratings History for Bioanalytical System (NASDAQ:BASI) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/21/2014TheStreetDowngradeHold -> SellView 5/15/2012Ladenburg ThalmannLower Price Target$2.25View (Data available from 3/11/2012 forward) Earnings History for Bioanalytical System (NASDAQ:BASI)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/13/2014Q114$0.00$0.04$5.80 million$6.22 millionViewN/AView 12/24/2013Q4 13$0.00$0.03$6.54 million$5.51 millionViewN/AView 10/18/2013Q313$0.01$0.07$5.65 million$5.60 millionViewN/AView 5/15/2013Q2 2013$0.01($0.02)$5.74 million$5.16 millionViewListenView 2/14/2013Q1 2013($0.03)$0.02$6.65 million$5.80 millionViewListenView (Data available from 1/1/2011 forward) Dividend History for Bioanalytical System (NASDAQ:BASI)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Bioanalytical System (NASDAQ:BASI)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare8/17/2012David L OmachinskiDirectorBuy10,000$1.26$12,600.00View 8/17/2012Jacqueline M LemkeCEOBuy20,000$1.26$25,200.00View (Data available from 1/1/2013 forward) About Bioanalytical System Bioanalytical Systems, Inc. and its subsidiaries are engaged in research services and other services related to pharmaceutical development. The Company also manufactures scientific instruments for medical research, which it sells with related software for use in industrial, governmental and academic laboratories. The Company operates in two business segments: contract research services and research products. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The Company designs, develops, manufactures and markets in vivo sampling systems and accessories, including disposables, training and systems qualification; physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms. Headlines: (2/13) BASi Reports First Quarter Results (2/13) Bioanalytical Systems revenue increases 7.2% in first quarter of fiscal 2014 Industry, Sector and Symbol: Sector: Services Industry: N/A Sub-Industry: N/A Exchange: NASDAQ Symbol: BASI CUSIP: Key Metrics: Previous Close: $2.8050 Day Moving Average: $2.9668200 Day Moving Average: $2.1806 P/E Ratio: N/AP/E Growth: N/AMarket Cap: $22.3MCurrent Quarter EPS Consensus Estimate: $0.00 EPS Additional Links: View BASI on Google FinanceView BASI on Yahoo FinanceView BASI's Company Profile on ReutersSearch for Bioanalytical System on Google Bioanalytical System (NASDAQ:BASI) Chart for Tuesday, March, 11, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.